Subscribe
ugisrigba
Ugis Rigba / Shutterstock.com
11 June 2020EuropeRory O'Neill

Unitary SPC should follow new patent system: EC official

The European Commission wants to implement a unitary supplementary protection certificate (SPC), its top IP official has said.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Why Santen ends Neurim-style SPCs
25 August 2020   In a boost for generic pharma companies, a U-turn by the EU’s highest court removed protection for repurposed active substances, as Robert Stephen and Gareth Morgan of CMS Cameron McKenna Nabarro Olswang explain.
Biotechnology
Kymab victorious before UK Supreme Court in Regeneron appeal
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.
Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Big Pharma
Why Santen ends Neurim-style SPCs
25 August 2020   In a boost for generic pharma companies, a U-turn by the EU’s highest court removed protection for repurposed active substances, as Robert Stephen and Gareth Morgan of CMS Cameron McKenna Nabarro Olswang explain.
Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.
Biotechnology
Kymab victorious before UK Supreme Court in Regeneron appeal
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.

More on this story

Big Pharma
Why Santen ends Neurim-style SPCs
25 August 2020   In a boost for generic pharma companies, a U-turn by the EU’s highest court removed protection for repurposed active substances, as Robert Stephen and Gareth Morgan of CMS Cameron McKenna Nabarro Olswang explain.
Generics
CJEU ‘shuts door’ on SPCs for second medical uses
10 July 2020   The EU’s top court has ruled out extra exclusivity rewards to drug companies for products with a second medical use.
Biotechnology
Kymab victorious before UK Supreme Court in Regeneron appeal
24 June 2020   The UK Supreme Court today has sided with biopharmaceutical company Kymab, allowing its appeal in a suit involving Regeneron and patents covering transgenic mice.

More features

President Trump 2.0: Five major areas to watch
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court